Chemoprevention of liver cancer by plant polyphenols

Food and Chemical Toxicology

Volumn 50, Issue 6, 2012, Pages 2155-2170

  Stagos, Dimitrios ^a   Amoutzias, Gregorios D ^a   Matakos, Antonios ^a   Spyrou, Argyris ^a   Tsatsakis, Aristides M ^b   Kouretas, Dimitrios ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Chemoprevention; Liver cancer; Plant polyphenols

Indexed keywords

ACACETIN; CAFFEIC ACID; CAFFEIC ACID PHENETHYL ESTER; CAPSAICIN; CARBOPLATIN; CASPASE; CAVEOLIN 1; CURCUMIN; CYCLIN DEPENDENT KINASE; DAIDZEIN; DOXORUBICIN; ELLAGIC ACID; EPIGALLOCATECHIN GALLATE; FLAVONOID; FLUOROURACIL; GENISTEIN; GLUTATHIONE; LUTEOLIN; MICRORNA; PACLITAXEL; PLANT POLYPHENOL; POLYPHENOL DERIVATIVE; PROTEIN P53; PROTOCATECHUIC ACID; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SILIBININ; SILYMARIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER INHIBITION; CANCER PREVENTION; CELL CYCLE ARREST; CELL INVASION; COLORECTAL CANCER; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER TUMOR; M PHASE CELL CYCLE CHECKPOINT; METASTASIS INHIBITION; MOUTH CANCER; NONHUMAN; PANCREAS CANCER; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; UTERINE CERVIX CANCER;

ANIMALS; ANTICARCINOGENIC AGENTS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; FEMALE; FLAVONOIDS; LIVER NEOPLASMS; MALE; MICE; PLANTS; POLYPHENOLS; RATS;

EID: 84860332038     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.04.002     Document Type: Review

References (199)

1. Ahn W.S., Yoo J., Huh S.W., Kim C.K., Lee J.M., Namkoong S.E., Bae S.M., Lee I.P. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur. J. Cancer Prev. 2003, 12:383-390.
2. Arola-Arnal A., Blade C. Proanthocyanidins modulate MicroRNA expression in human HepG2 cells. PLoS One 2011, 6:25982.
3. Bae M.K., Kim S.H., Jeong J.W., Lee Y.M., Kim H.S., Kim S.R., Yun I., Bae S.K., Kim K.W. Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1. Oncol. Rep. 2006, 15:1557-1562.
4. Baek Y.M., Hwang H.J., Kim S.W., Hwang H.S., Lee S.H., Kim J.A., Yun J.W. A comparative proteomic analysis for capsaicin-induced apoptosis between human hepatocarcinoma (HepG2) and human neuroblastoma (SK-N-SH) cells. Proteomics 2008, 8:4748-4767.
5. Beltrán-Ramírez O., Alemán-Lazarini L., Salcido-Neyoy M., Hernández-García S., Fattel-Fazenda S., Arce-Popoca E., Arellanes-Robledo J., García-Román R., Vázquez-Vázquez P., Sierra-Santoyo A., Villa-Treviño S. Evidence that the anticarcinogenic effect of caffeic acid phenethyl ester in the resistant hepatocyte model involves modifications of cytochrome P450. Toxicol. Sci. 2008, 104:100-106.
6. Bishayee A., Dhir N. Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis. Chem. Biol. Interact. 2009, 179:131-144.
7. Bishayee A., Barnes K.F., Bhatia D., Darvesh A.S., Carroll R.T. Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis. Cancer Prev. Res. 2010, 3:753-763.
8. Bishayee A., Waghray A., Barnes K.F., Mbimba T., Bhatia D., Chatterjee M., Darvesh A.S. Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis. Pharm. Res. 2010, 27:1080-1091.
9. Bishayee A., Politis T., Darvesh A.S. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma. Cancer Treat. Rev. 2010, 36:43-53.
10. Bode A.M., Dong Z. The two faces of capsaicin. Cancer Res. 2011, 71(8):2809-2814.
11. Bonifaz V., Shan Y., Lambrecht R.W., Donohue S.E., Moschenross D., Bonkovsky H.L. Effects of silymarin on hepatitis C virus and haem oxygenase-1 gene expression in human hepatoma cells. Liver Int. 2009, 29:366-373.
12. Bosch F.X., Ribes J., Borràs J. Epidemiology of primary liver cancer. Semin. Liver Dis. 1999, 19:271-285.
13. Bosch F.X., Ribes J., Cléries R., Díaz M. Epidemiology of hepatocellular carcinoma. Clin. Liver Dis. 2005, 9:191-211.
14. Brown V.A., Patel K.R., Viskaduraki M., Crowell J.A., Perloff M., Booth T.D., Vasilinin G., Sen A., Schinas A.M., Piccirilli G., Brown K., Steward W.P., Gescher A.J., Brenner D.E. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics and effect on the insulin-like growth factor axis. Cancer Res. 2010, 70:9003-9011.
15. Brückner M., Westphal S., Domschke W., Kucharzik T., Lügering A. Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis. J. Crohns Colitis 2012, 6(2):226-235.
16. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 2004, 1:2999-3004.
17. Cammà C., Giunta M., Andreone P., Craxì A. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach. J. Hepatol. 2001, 34:593-602.
18. Brisdelli F., D'Andrea G., Bozzi A. Resveratrol: a natural polyphenol with multiple chemopreventive properties. Curr. Drug Metab. 2009, 10:530-546.
19. Campagna M., Rivas C. Antiviral activity of resveratrol. Biochem. Soc. Trans. 2010, 38:50-53.
20. Canistro D., Bonamassa B., Pozzetti L., Sapone A., Abdel-Rahman S.Z., Biagi G.L., Paolini M. Alteration of xenobiotic metabolizing enzymes by resveratrol in liver and lung of CD1 mice. Food Chem. Toxicol. 2009, 47:454-461.
21. Cao J., Jia L., Zhou H.M., Liu Y., Zhong L.F. Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells. Toxicol. Sci. 2006, 91:476-483.
22. Cao J., Liu Y., Jia L., Zhou H.M., Kong Y., Yang G., Jiang L.P., Li Q.J., Zhong L.F. Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells. Free Radic. Biol. Med. 2007, 43:968-975.
23. Cao J., Xu Y., Chen J., Klaunig J.E. Chemopreventive effects of green and black tea on pulmonary and hepatic carcinogenesis. Fundam. Appl. Toxicol. 1996, 29(2):244-250.
24. Carrasco-Legleu C.E., Márquez-Rosado L., Fattel-Fazenda S., Arce-Popoca E., Pérez-Carreón J.I., Villa-Treviño S. Chemoprotective effect of caffeic acid phenethyl ester on promotion in a medium-term rat hepatocarcinogenesis assay. Int. J. Cancer 2004, 108:488-492.
25. Carrasco-Legleu C.E., Sánchez-Pérez Y., Márquez-Rosado L., Fattel-Fazenda S., Arce-Popoca E., Hernández-García S., Villa-Treviño S. A single dose of caffeic acid phenethyl ester prevents initiation in a medium-term rat hepatocarcinogenesis model. World J. Gastroenterol. 2006, 12:6779-6785.
26. Chang M.H., Chen C.J., Lai M.S., Hsu H.M., Wu T.C., Kong M.S., Liang D.C., Shau W.Y., Chen D.S. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N. Engl. J. Med. 1997, 336:1855-1859.
27. Chang J., Hsu Y., Kuo P., Kuo Y., Chiang L., Lin C. Increase of Bax/Bcl-XL ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line. Life Sci. 2005, 76:1883-1893.
28. Chang Y.F., Chi C.W., Wang J.J. Reactive oxygen species production is involved in quercetin-induced apoptosis in human hepatoma cells. Nutr. Cancer 2006, 55:201-209.
29. Chen Y.J., Yeh S.H., Chen J.T., Wu C.C., Hsu M.T., Tsai S.F., Chen P.J., Lin C.H. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology 2000, 119:431-440.
30. Chen Y., Huang C., Zhou T., Chen G. Genistein induction of human sulfotransferases in HepG2 and Caco-2 cells. Basic Clin. Pharmacol. Toxicol. 2008, 103:553-559.
31. Chen C.H., Huang T.S., Wong C.H., Hong C.L., Tsai Y.H., Liang C.C., Lu F.J., Chang W.H. Synergistic anti-cancer effect of baicalein and silymarin on human hepatoma HepG2 Cells. Food Chem. Toxicol. 2009, 47:638-644.
32. Cheng C.Y., Lin Y.H., Su C.C. Curcumin inhibits the proliferation of human hepatocellular carcinoma J5 cells by inducing endoplasmic reticulum stress and mitochondrial dysfunction. Int. J. Mol. Med. 2010, 26:673-678.
33. Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., Ko J.Y., Lin J.T., Lin B.R., Ming-Shiang W., Yu H.S., Jee S.H., Chen G.S., Chen T.M., Chen C.A., Lai M.K., Pu Y.S., Pan M.H., Wang Y.J., Tsai C.C., Hsieh C.Y. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001, 21:2895-2900.
34. Chidlow J.H., Sessa W.C. Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. Cardiovasc. Res. 2010, 86:219-225.
35. Chodon D., Ramamurty N., Sakthisekaran D. Preliminary studies on induction of apoptosis by genistein on HepG2 cell line. Toxicol. In Vitro 2007, 21:887-891.
36. Choi K.C., Chung W.T., Kwon J.K., Yu J.Y., Jang Y.S., Park S.M., Lee S.Y., Lee J.C. Inhibitory effects of quercetin on aflatoxin B1-induced hepatic damage in mice. Food Chem. Toxicol. 2010, 48:2747-2753.
37. Chowdhury A.R., Sharma S., Mandal S., Goswami A., Mukhopadhyay S., Majumder H.K. Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I. Biochem. J. 2002, 366:653-661.
38. Chuang S.E., Kuo M.L., Hsu C.H., Chen C.R., Lin J.K., Lai G.M., Hsieh C.Y., Cheng A.L. Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis 2000, 21:331-335.
39. Chung T.W., Moon S.K., Chang Y.C., Ko J.H., Lee Y.C., Cho G., Kim S.H., Kim J.G., Kim C.H. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J. 2004, 18:1670-1681.
40. Cui W., Gu F., Hu K.Q. Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice. World J. Gastroenterol. 2009, 15:1943-1950.
41. Curley S.A., Izzo F. Radiofrequency ablation of primary and metastatic liver tumors. Surg. Technol. Int. 2002, 10:99-106.
42. Das M., Das D.K. Resveratrol and cardiovascular health. Mol. Aspects Med. 2010, 31:503-512.
43. De Lédinghen V., Monvoisin A., Neaud V., Krisa S., Payrastre B., Bedin C., Desmoulière A., Bioulac-Sage P., Rosenbaum J. Trans-resveratrol, a grapevine-derived polyphenol, blocks hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells. Int. J. Oncol. 2001, 19:83-88.
44. deVere White R.W., Hackman R.M., Soares S.E., Beckett L.A., Li Y., Sun B. Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer. Urology 2004, 63:259-263.
45. Delmas D., Jannin B., Cherkaoui Malki M., Latruffe N. Inhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell lines. Oncol. Rep. 2000, 7:847-852.
46. Dhillon N., Aggarwal B.B., Newman R.A., Wolff R.A., Kunnumakkara A.B., Abbruzzese J.L., Ng C.S., Badmaev V., Kurzrock R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 2008, 14:4491-4499.
47. Ebara M., Ohto M., Sugiura N., Kita K., Yoshikawa M., Okuda K., Kondo F., Kondo Y. Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients. J. Gastroenterol. Hepatol. 1990, 5:616-626.
48. Eguchi H., Umeshita K., Sakon M., Nagano H., Ito Y., Kishimoto S.I., Dono K., Nakamori S., Takeda T., Gotoh M., Wakasa K., Matsuura N., Monden M. Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failure. Dig. Dis. Sci. 2000, 45:1383-1388.
49. El-Serag H.B. Epidemiology of hepatocellular carcinoma. Clin. Liver Dis. 2001, 5:87-107.
50. El-Serag H.B., Tran T., Everhart J.E. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004, 126:460-468.
51. García-Maceira P., Mateo J. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy. Oncogene 2009, 28:313-324.
52. Garzon R., Pichiorri F., Palumbo T., Visentini M., Aqeilan R., Cimmino A., Wang H., Sun H., Volinia S., Alder H., Calin G.A., Liu C.G., Andreeff M., Croce C.M. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 2007, 26:4148-4157.
53. Gharavi N., El-Kadi A.O. Tert-Butylhydroquinone is a novel aryl hydrocarbon receptor ligand. Drug Metab. Dispos. 2005, 33:365-372.
54. Glauert H.P., Calfee-Mason K., Stemm D.N., Tharappel J.C., Spear B.T. Dietary antioxidants in the prevention of hepatocarcinogenesis: a review. Mol. Nutr. Food Res. 2010, 54(7):875-896.
55. Granado-Serrano A.B., Angeles Martin M., Bravo L., Goya L., Ramos S. Time-course regulation of quercetin on cell survival/proliferation pathways in human hepatoma cells. Mol. Nutr. Food Res. 2008, 52:457-464.
56. Granado-Serrano A.B., Martin M.A., Bravo L., Goya L., Ramos S. Quercetin modulates NF-kappa B and AP-1/JNK pathways to induce cell death in human hepatoma cells. Nutr. Cancer 2010, 62:390-401.
57. Gu Y., Zhu C.F., Iwamoto H., Chen J.S. Genistein inhibits invasive potential of human hepatocellular carcinoma by altering cell cycle, apoptosis, and angiogenesis. World J. Gastroenterol. 2005, 11:6512-6517.
58. Gu Y., Zhu C.F., Dai Y.L., Zhong Q., Sun B. Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma. World J. Gastroenterol. 2009, 15:4952-4957.
59. Hagiwara A., Kokubo Y., Takesada Y., Tanaka H., Tamano S., Hirose M., Shirai T., Ito N. Inhibitory effects of phenolic compounds on development of naturally occurring preneoplastic hepatocytic foci in long-term feeding studies using male F344 rats. Teratog. Carcinog. Mutagen. 1996, 16:317-325.
60. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
61. Hsu Y.L., Kuo P.L., Lin C.C. Acacetin inhibits the proliferation of Hep G2 by blocking cell cycle progression and inducing apoptosis. Biochem. Pharmacol. 2004, 67:823-829.
62. Horgan, A.M., Dawson, L.A., Swaminath, A., Knox, J.J., 2010. Sorafenib and radiation therapy for the treatment of advanced hepatocellular carcinoma. J. Gastrointest. Cancer. [Epub ahead of print].
63. Hirose M., Takahashi S., Ogawa K., Futakuchi M., Shirai T., Shibutani M., Uneyama C., Toyoda K., Iwata H. Chemoprevention of heterocyclic amine-induced carcinogenesis by phenolic compounds in rats. Cancer Lett. 1999, 143(2):173-178.
64. Hirose M., Hasegawa R., Kimura J., Akagi K., Yoshida Y., Tanaka H., Miki T., Satoh T., Wakabayashi K., Ito N., et al. Inhibitory effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx). Carcinogenesis 1995, 16(12):3049-3055.
65. Huang A.C., Lin S.Y., Su C.C., Lin S.S., Ho C.C., Hsia T.C., Chiu T.H., Yu C.S., Ip S.W., Lin T.P., Chung J.G. Effects of curcumin on N-bis(2-hydroxypropyl) nitrosamine (DHPN)-induced lung and liver tumorigenesis in BALB/c mice in vivo. In vivo 2008, 22:781-785.
66. Huang S.P., Chen J.C., Wu C.C., Chen C.T., Tang N.Y., Ho Y.T., Lo C., Lin J.P., Chung J.G., Lin J.G. Capsaicin-induced apoptosis in human hepatoma HepG2 cells. Anticancer Res. 2009, 29:165-174.
67. Ikeda K., Kumada H., Saitoh S., Arase Y., Chayama K. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model. Cancer 1991, 68:2150-2154.
68. Iqbal M., Sharma S.D., Okazaki Y., Fujisawa M., Okada S. Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity. Pharmacol. Toxicol. 2003, 92:33-38.
69. Ito K., Nakazato T., Yamato K., Miyakawa Y., Yamada T., Hozumi N., Segawa K., Ikeda Y., Kizaki M. Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Res. 2004, 64:1071-1078.
70. Jeandet P., Douillet-Breuil A.C., Bessis R., Debord S., Sbaghi M., Adrian M. Phytoalexins from the Vitaceae: biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity, and metabolism. J. Agric. Food Chem. 2002, 50:2731-2741.
71. Jiang M.C., Yang-Yen H.F., Lin J.K., Yen J.J. Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells. Oncogene 1996, 13:609-616.
72. Jin U.H., Chung T.W., Kang S.K., Suh S.J., Kim J.K., Chung K.H., Gu Y.H., Suzuki I., Kim C.H. Caffeic acid phenyl ester in propolis is a strong inhibitor of matrix metalloproteinase-9 and invasion inhibitor: isolation and identification. Clin. Chim. Acta 2005, 362:57-64.
73. Jin C.Y., Park C., Kim G.Y., Lee S.J., Kim W.J., Choi Y.H. Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells. Chem. Biol. Interact. 2009, 180:143-150.
74. Jin C.Y., Park C., Moon S.K., Kim G.Y., Kwon T.K., Lee S.J., Kim W.J., Choi Y.H. Genistein sensitizes human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by enhancing Bid cleavage. Anticancer Drugs 2009, 20:713-722.
75. Joung E.J., Li M.H., Lee H.G., Somparn N., Jung Y.S., Na H.K., Kim S.H., Cha Y.N., Surh Y.J. Capsaicin induces heme oxygenase-1 expression in HepG2 cells via activation of PI3K-Nrf2 signaling: NAD(P)H:quinone oxidoreductase as a potential target. Antioxid. Redox Signal. 2007, 9:2087-2098.
76. Joo J.H., Kim J.W., Lee Y., Yoon S.Y., Kim J.H., Paik S.G., Choe I.S. Involvement of NF-kappaB in the regulation of S100A6 gene expression in human hepatoblastoma cell line HepG2. Biochem. Biophys. Res. Commun. 2003, 307:274-280.
77. Jung M.Y., Kang H.J., Moon A. Capsaicin-induced apoptosis in SK-Hep-1 hepatocarcinoma cells involves Bcl-2 downregulation and caspase-3 activation. Cancer Lett. 2001, 165:139-145.
78. Kaur M., Agarwal R. Silymarin and epithelial cancer chemoprevention: how close we are to bedside?. Toxicol. Appl. Pharmacol. 2007, 224(3):350-359.
79. Kampkötter A., Wiegand C., Timpel C., Röhrdanz E., Chovolou Y., Kahl R., Wätjen W. Increased expression of catalase in human hepatoma cells by the soy isoflavone, daidzein. Basic Clin. Pharmacol. Toxicol. 2008, 102:437-442.
80. Kasahara A., Hayashi N., Mochizuki K., Takayanagi M., Yoshioka K., Kakumu S., Iijima A., Urushihara A., Kiyosawa K., Okuda M., Hino K., Okita K. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology 1998, 27:1394-1402.
81. Kaufmann R., Henklein P., Henklein P., Settmacher U. Green tea polyphenol epigallocatechin-3-gallate inhibits thrombin-induced hepatocellular carcinoma cell invasion and p42/p44-MAPKinase activation. Oncol. Rep. 2009, 21:1261-1267.
82. Khanduja K.L., Bhardwaj A., Kaushik G. Resveratrol inhibits N-nitrosodiethylamine-induced ornithine decarboxylase and cyclooxygenase in mice. J. Nutr. Sci. Vitaminol. 2004, 50:61-65.
83. 2+ release pathway mediates the capsaicin-induced apoptosis in HepG2 human hepatoma cells. Arch. Pharm. Res. 2005, 28:73-80.
84. Kim J.Y., Kim E.H., Park S.S., Lim J.H., Kwon T.K., Choi K.S. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation. J. Cell Biochem. 2008, 105:1386-1398.
85. Kocsis Z., Marcsek Z.L., Jakab M.G., Szende B., Tompa A. Chemopreventive properties of trans-resveratrol against the cytotoxicity of chloroacetanilide herbicides in vitro. Int. J. Hyg. Environ. Health 2005, 208:211-218.
86. Korkina L.G., De Luca C., Kostyuk V.A., Pastore S. Plant polyphenols and tumors: from mechanisms to therapies, prevention, and protection against toxicity of anti-cancer treatments. Curr. Med. Chem. 2009, 16:3943-3965.
87. Kozuki Y., Miura Y., Yagasaki K. Resveratrol suppresses hepatoma cell invasion independently of its anti-proliferative action. Cancer Lett. 2001, 167:151-156.
88. Kuo P.L., Chiang L.C., Lin C.C. Resveratrol- induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci. 2002, 72:23-34.
89. Kuo P.L., Lin C.C. Green tea constituent (-)-epigallocatechin-3-gallate inhibits Hep G2 cell proliferation and induces apoptosis through p53-dependent and Fas-mediated pathways. J. Biomed. Sci. 2003, 10:219-227.
90. Kurahashi N., Inoue M., Iwasaki M., Tanaka Y., Mizokami M., Tsugane S. Isoflavone consumption and subsequent risk of hepatocellular carcinoma in a population-based prospective cohort of Japanese men and women. Int. J. Cancer 2009, 124:1644-1649. JPHC Study Group.
91. Lee K.W., Chun K.S., Lee J.S., Kang K.S., Surh Y.J., Lee H.J. Inhibition of cyclooxygenase-2 expression and restoration of gap junction intercellular communication in H-ras-transformed rat liver epithelial cells by caffeic acid phenethyl ester. Ann. NY Acad. Sci. 2004, 1030:501-507.
92. Lee Y.S., Kang Y.S., Lee J.S., Nicolova S., Kim J.A. Involvement of NADPH oxidase-mediated generation of reactive oxygen species in the apototic cell death by capsaicin in HepG2 human hepatoma cells. Free Radic. Res. 2004, 38(4):405-412.
93. Lee Y.S. Role of NADPH oxidase-mediated generation of reactive oxygen species in the mechanism of apoptosis induced by phenolic acids in HepG2 human hepatoma cells. Arch. Pharm. Res. 2005, 28:1183-1189.
94. Lee W.J., Wu L.F., Chen W.K., Wang C.J., Tseng T.H. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways. Chem. Biol. Interact. 2006, 160:123-133.
95. Lee S.J., Lee K.W., Hur H.J., Chun J.Y., Kim S.Y., Lee H.J. Phenolic phytochemicals derived from red pine (Pinus densiflora) inhibit the invasion and migration of SK-Hep-1 human hepatocellular carcinoma cells. Ann. NY Acad. Sci. 2007, 1095:536-544.
96. Li W., Nie S., Yu Q., Xie M. (-)-Epigallocatechin-3-gallate induces apoptosis of human hepatoma cells by mitochondrial pathways related to reactive oxygen species. J. Agric. Food Chem. 2009, 57:6685-6691.
97. Li Y., Kong D., Wang Z., Sarkar F.H. Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharm. Res. 2010, 27:1027-1041.
98. Liang G., Tang A., Lin X., Li L., Zhang S., Huang Z., Tang H., Li Q.Q. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int. J. Oncol. 2010, 37:111-123.
99. Lin L.I., Ke Y.F., Ko Y.C., Lin J.K. Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion. Oncology 1998, 55:349-353.
100. Loa J., Chow P., Zhang K. Studies of structure-activity relationship on plant polyphenol-induced suppression of human liver cancer cells. Cancer Chemother. Pharmacol. 2009, 63:1007-1016.
101. Lopez-Carrillo L., Hernandez Avila M., Dubrow R. Chili pepper consumption and gastric cancer in Mexico: a case-control study. Am. J. Epidemiol. 1994, 139:263-271.
102. Lu L., Liu H.M., Tang W.X. Effect of epigallocatechin-3-gallate on the invasiveness of hepatocarcinoma cells in vitro. Zhonghua Gan Zang Bing Za Zhi. 2007, 15:825-827.
103. Luo X.J., Peng J., Li Y.J. Recent advances in the study on capsaicinoids and capsinoids. Eur. J. Pharmacol. 2011, 10, 650(1):1-7.
104. Luther D.J., Ohanyan V., Shamhart P.E., Hodnichak C.M., Sisakian H., Booth T.D., Meszaros J.G., Bishayee A. Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma. Invest. New Drugs 2011, 29:380-391.
105. Manach C., Scalbert A., Morand C., Rémésy C., Jiménez L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79:727-747.
106. Mann C.D., Neal C.P., Garcea G., Manson M.M., Dennison A.R., Berry D.P. Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis. Eur. J. Cancer Prev. 2009, 18(1):13-25.
107. Matsumoto N., Kohri T., Okushio K., Hara Y. Inhibitory effects of tea catechins, black tea extract and oolong tea extract on hepatocarcinogenesis in rat. Jpn. J. Cancer Res. 1996, 87:1034-1048.
108. Meng F., Wehbe-Janek H., Henson R., Smith H., Patel T. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene 2008, 27:378-386.
109. Michels G., Wätjen W., Niering P., Steffan B., Thi Q.H., Chovolou Y., Kampkötter A., Bast A., Proksch P., Kahl R. Pro-apoptotic effects of the flavonoid luteolin in rat H4IIE cells. Toxicology 2005, 206:337-348.
110. Michels G., Wätjen W., Weber N., Niering P., Chovolou Y., Kampkötter A., Proksch P., Kahl R. Resveratrol induces apoptotic cell death in rat H4IIE hepatoma cells but necrosis in C6 glioma cells. Toxicology 2006, 225:173-182.
111. Michielsen P.P., Francque S.M., van Dongen J.L. Viral hepatitis and hepatocellular carcinoma. World J. Surg. Oncol. 2005, 20:27.
112. Mimeault M., Batra S.K. Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy. Chin. Med. 2011, 23(6):31.
113. Mishra P., Kar A., Kale R.K. Prevention of chemically induced mammary tumorigenesis by daidzein in pre-pubertal rats: the role of peroxidative damage and antioxidative enzymes. Mol. Cell Biochem. 2009, 325:149-157.
114. Miura D., Miura Y., Yagasaki K. Resveratrol inhibits hepatoma cell invasion by suppressing gene expression of hepatocyte growth factor via its reactive oxygen species-scavenging property. Clin. Exp. Metastasis 2004, 21:445-451.
115. Momeny M., Khorramizadeh M.R., Ghaffari S.H., Yousefi M., Yekaninejad M.S., Esmaeili R., Jahanshiri Z., Nooridaloii M.R. Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation. Eur. J. Pharmacol. 2008, 591:13-20.
116. Moriwaki H. Prevention of liver cancer: basic and clinical aspects. Exp. Mol. Med. 2002, 34:319-325.
117. Murakami Y., Yasuda T., Saigo K., Urashima T., Toyoda H., Okanoue T., Shimotohno K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006, 25:2537-2545.
118. Na H.K., Wilson M.R., Kang K.S., Chang C.C., Grunberger D., Trosko J.E. Restoration of gap junctional intercellular communication by caffeic acid phenethyl ester (CAPE) in a ras-transformed rat liver epithelial cell line. Cancer Lett. 2000, 157:31-38.
119. Nagasue N., Kohno H., Tachibana M., Yamanoi A., Ohmori H., El-Assal O.N. Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis. Ann. Surg. 1999, 229:84-90.
120. Neuschwander-Tetri B.A., Caldwell S.H. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003, 37:1202-1219.
121. Ning L., Wentworth L., Chen H., Weber S.M. Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinoma. Am. J. Trans. Res. 2009, 1:358-366.
122. Nishida H., Omori M., Fukutomi Y., Ninomiya M., Nishiwaki S., Suganuma M., Moriwaki H., Muto Y. Inhibitory effects of (-)-epigallocatechin gallate on spontaneous hepatoma in C3H/HeNCrj mice and human hepatoma-derived PLC/PRF/5 cells. Jpn. J. Cancer Res. 1994, 85:221-225.
123. Nishikawa T., Nakajima T., Moriguchi M., Jo M., Sekoguchi S., Ishii M., Takashima H., Katagishi T., Kimura H., Minami M., Itoh Y., Kagawa K., Okanoue T. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. J. Hepatol. 2006, 44:1074-1082.
124. Nordenstedt H., White D.L., El-Serag H.B. The changing pattern of epidemiology in hepatocellular carcinoma. Dig. Liver Dis. 2010, 42(Suppl. 1):206-214.
125. Notarbartolo M., Poma P., Perri D., Dusonchet L., Cervello M., D'Alessandro N. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Cancer Lett. 2005, 224:53-65.
126. Notas G., Nifli A.P., Kampa M., Vercauteren J., Kouroumalis E., Castanas E. Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation. Biochim. Biophys. Acta 2006, 1760:1657-1666.
127. Ohashi Y., Tsuchiya Y., Koizumi K., Sakurai H., Saiki I. Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model. Oncology 2003, 65:250-258.
128. Oi N., Hashimoto T., Kanazawa K. Metabolic conversion of dietary quercetin from its conjugate to active aglycone following the induction of hepatocarcinogenesis in fisher 344 rats. J. Agric. Food Chem. 2008, 56:577-583.
129. Pan M.H., Chiou Y.S., Chen W.J., Wang J.M., Badmaev V., Ho C.T. Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. Carcinogenesis 2009, 30:1234-1242.
130. Pang R., Tse E., Poon R.T. Molecular pathways in hepatocellular carcinoma. Cancer Lett. 2006, 240:157-169.
131. Parekh P., Motiwale L., Naik N., Rao K.V. Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells. Exp. Toxicol. Pathol. 2011, 63:167-173.
132. Pares A., Planas R., Torres M., Caballeria J., Viver J.M., Acero D., Panes J., Rigau J., Santos J., Rodes J. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J. Hepatol. 1998, 28:615-621.
133. Park J.H., Oh E.J., Choi Y.H., Kang C.D., Kang H.S., Kim D.K., Kang K.I., Yoo M.A. Synergistic effects of dexamethasone and genistein on the expression of Cdk inhibitor p21WAF1/CIP1 in human hepatocellular and colorectal carcinoma cells. Int. J. Oncol. 2001, 18:997-1002.
134. Parkin D.M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 2001, 94:153-156.
135. Patel K.R., Brown V.A., Jones D.J., Britton R.G., Hemingway D., et al. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 2010, 70:7392-7399.
136. Perabo F.G., Von Löw E.C., Ellinger J., von Rücker A., Müller S.C., Bastian P.J. Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Prostatic Dis. 2008, 11(1):6-12.
137. Pereira M.A. Chemoprevention of diethylnitrosamine-induced liver foci and hepatocellular adenomas in C3H mice. Anticancer Res. 1995, 15:1953-1956.
138. Piper J.T., Singhal S.S., Salameh M.S., Torman R.T., Awasthi Y.C., Awasthi S. Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver. Int. J. Biochem. Cell Biol. 1998, 30:445-456.
139. Poon R.T., Fan S.T., Tsang F.H., Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann. Surg. 2002, 235:466-486.
140. Poon R.T., Fan S.T. Resection prior to liver transplantation for hepatocellular carcinoma: a strategy of optimizing the role of resection and transplantation in cirrhotic patients with preserved liver function. Liver Transpl. 2004, 10:813-815.
141. Queen B.L., Tollefsbol T.O. Polyphenols and aging. Curr. Aging Sci. 2010, 3:34-42.
142. Ramos S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol. Nutr. Food Res. 2008, 52:507-526.
143. Ramakrishnan G., Raghavendran H.R., Vinodhkumar R., Devaki T. Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats. Chem. Biol. Interact. 2006, 161:104-114.
144. Ramakrishnan G., Lo Muzio L., Elinos-Báez C.M., Jagan S., Augustine T.A., Kamaraj S., Anandakumar P., Devaki T. Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells. Cell Prolif. 2009, 42:229-240.
145. Ramakrishnan G., Jagan S., Kamaraj S., Anandakumar P., Devaki T. Silymarin attenuated mast cell recruitment thereby decreased the expressions of matrix metalloproteinases-2 and 9 in rat liver carcinogenesis. Invest. New Drugs 2009, 27:233-240.
146. Robb E.L., Stuart J.A. Trans-Resveratrol as a neuroprotectant. Molecules 2010, 15:1196-1212.
147. Robbins R.J. Phenolic acids in foods: an overview of analytical methodology. J. Agric. Food Chem. 2003, 51:2866-2887.
148. Röhrdanz E., Ohler S., Tran-Thi Q.H., Kahl R. The phytoestrogen daidzein affects the antioxidant enzyme system of rat hepatoma H4IIE cells. J. Nutr. 2002, 132:370-375.
149. Rosa A., Ballarino M., Sorrentino A., Sthandier O., De Angelis F.G., Marchioni M., Masella B., Guarini A., Fatica A., Peschle C., Bozzoni I. The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc. Natl. Acad. Sci. USA 2007, 104:19849-19854.
150. Russo M., Spagnuolo C., Tedesco I., Bilotto S., Russo G.L. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem. Pharmacol. 2012, 83(1):6-15.
151. Sánchez-Pérez Y., Carrasco-Legleu C., García-Cuellar C., Pérez-Carreón J., Hernández-García S., Salcido-Neyoy M., Alemán-Lazarini L., Villa-Treviño S. Oxidative stress in carcinogenesis. Correlation between lipid peroxidation and induction of preneoplastic lesions in rat hepatocarcinogenesis. Cancer Lett. 2005, 217:25-32.
152. Selvendiran K., Koga H., Ueno T., Yoshida T., Maeyama M., Torimura T., Yano H., Kojiro M., Sata M. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids. Cancer Res. 2006, 66:4826-4834.
153. Sempere L.F., Christensen M., Silahtaroglu A., Bak M., Heath C.V., Schwartz G., Wells W., Kauppinen S., Cole C.N. Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res. 2007, 67:11612-11620.
154. Seren S., Mutchnick M., Hutchinson D., Harmanci O., Bayraktar Y., Mutchnick S., Sahin K., Kucuk O. Potential role of lycopene in the treatment of hepatitis C and prevention of hepatocellular carcinoma. Nutr. Cancer 2008, 60(6):729-735.
155. Seufi A.M., Ibrahim S.S., Elmaghraby T.K., Hafez E.E. Preventive effect of the flavonoid, quercetin, on hepatic cancer in rats via oxidant/antioxidant activity: molecular and histological evidences. J. Exp. Clin. Cancer Res. 2009, 28:80.
156. Shahani K., Panyam J. Highly loaded, sustained-release microparticles of curcumin for chemoprevention. J. Pharm. Sci. 2011, 100(7):2599-2609.
157. Sharma A., Upadhyay A.K., Bhat M.K. Inhibition of Hsp27 and Hsp40 potentiates 5-fluorouracil and carboplatin mediated cell killing in hepatoma cells. Cancer Biol. Ther. 2009, 8:2106-2113.
158. Sharma R.A., McLelland H.R., Hill K.A., Ireson C.R., Euden S.A., Manson M.M., Pirmohamed M., Marnett L.J., Gescher A.J., Steward W.P. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin. Cancer Res. 2001, 7:1894-1900.
159. Shertzer H.G., Puga A., Chang C., Smith P., Nebert D.W., Setchell K.D., Dalton T.P. Inhibition of CYP1A1 enzyme activity in mouse hepatoma cell culture by soybean isoflavones. Chem. Biol. Interact. 1999, 123:31-49.
160. Shi L., Reid L.H., Jones W.D., Shippy R., Warrington J.A., Baker S.C., Collins P.J., de Longueville F., Kawasaki E.S., Lee K.Y., Luo Y., Sun Y.A., Willey J.C., Setterquist R.A., Fischer G.M., Tong W., Dragan Y.P., Dix D.J., Frueh F.W., Goodsaid F.M., Herman D., Jensen R.V., Johnson C.D., Lobenhofer E.K., Puri R.K., Schrf U., Thierry-Mieg J., Wang C., Wilson M., Wolber P.K., Zhang L., Amur S., Bao W., Barbacioru C.C., Lucas A.B., Bertholet V., Boysen C., Bromley B., Brown D., Brunner A., Canales R., Cao X.M., Cebula T.A., Chen J.J., Cheng J., Chu T.M., Chudin E., Corson J., Corton J.C., Croner L.J., Davies C., Davison T.S., Delenstarr G., Deng X., Dorris D., Eklund A.C., Fan X.H., Fang H., Fulmer-Smentek S., Fuscoe J.C., Gallagher K., Ge W., Guo L., Guo X., Hager J., Haje P.K., Han J., Han T., Harbottle H.C., Harris S.C., Hatchwell E., Hauser C.A., Hester S., Hong H., Hurban P., Jackson S.A., Ji H., Knight C.R., Kuo W.P., LeClerc J.E., Levy S., Li Q.Z., Liu C., Liu Y., Lombardi M.J., Ma Y., Magnuson S.R., Maqsodi B., McDaniel T., Mei N., Myklebost O., Ning B., Novoradovskaya N., Orr M.S., Osborn T.W., Papallo A., Patterson T.A., Perkins R.G., Peters E.H., Peterson R., Philips K.L., Pine P.S., Pusztai L., Qian F., Ren H., Rosen M., Rosenzweig B.A., Samaha R.R., Schena M., Schroth G.P., Shchegrova S., Smith D.D., Staedtler F., Su Z., Sun H., Szallasi Z., Tezak Z., Thierry-Mieg D., Thompson K.L., Tikhonova I., Turpaz Y., Vallanat B., Van C., Walker S.J., Wang S.J., Wang Y., Wolfinger R., Wong A., Wu J., Xiao C., Xie Q., Xu J., Yang W., Zhang L., Zhong S., Zong Y., Slikker W. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol. 2006, 24:1151-1161.
161. Shirakami Y., Shimizu M., Adachi S., Sakai H., Nakagawa T., Yasuda Y., Tsurumi H., Hara Y., Moriwaki H. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis. Cancer Sci. 2009, 100:1957-1962.
162. Shukla Y., Arora A. Suppression of altered hepatic foci development by curcumin in wistar rats. Nutr. Cancer 2003, 45:53-59.
163. Shukla S.K., Gupta S., Ojha S.K., Sharma S.B. Cardiovascular friendly natural products: a promising approach in the management of CVD. Nat. Prod. Res. 2010, 24:873-898.
164. Siess M.H., Le Bon A.M., Canivenc-Lavier M.C., Suschetet M. Mechanisms involved in the chemoprevention of flavonoids. Biofactors 2000, 12:193-199.
165. Soni K.B., Lahiri M., Chackradeo P., Bhide S.V., Kuttan R. Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocarcinogenicity. Cancer Lett. 1997, 115:129-133.
166. Sporn M.B., Liby K.T. Cancer chemoprevention: scientific promise, clinical uncertainty. Nat. Clin. Pract. Oncol. 2005, 2:518-525.
167. Sreepriya M., Bali G. Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats. Fitoterapia 2005, 76:549-555.
168. Stagos D., Spanou C., Margariti M., Stathopoulos C., Mamuris Z., Kazantzoglou G., Magiatis P., Kouretas D. Cytogenetic effects of grape extracts (Vitis vinifera) and polyphenols on mitomycin C-induced sister chromatid exchanges (SCEs) in human blood lymphocytes. J. Agric. Food Chem. 2007, 55:5246-5252.
169. Stervbo U., Vang O., Bonnesen C. Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells. Cell Prolif. 2006, 39:479-493.
170. Su S.J., Chow N.H., Kung M.L., Hung T.C., Chang K.L. Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity. Nutr Cancer 2003, 45:113-123.
171. Sun Z.J., Pan C.E., Liu H.S., Wang G.J. Anti-hepatoma activity of resveratrol in vitro. World J. Gastroenterol. 2002, 8:79-81.
172. Takayama T., Makuuchi M., Hirohashi S., Sakamoto M., Yamamoto J., Shimada K., Kosuge T., Okada S., Takayasu K., Yamasaki S. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 1998, 28:1241-1246.
173. Tamura K., Nakae D., Horiguchi K., Akai H., Kobayashi Y., Satoh H., Tsujiuchi T., Denda A., Konishi Y. Inhibition by green tea extract of diethylnitrosamine-initiated but not choline-deficient, l-amino acid-defined diet-associated development of putative preneoplastic, glutathione S-transferase placental form-positive lesions in rat liver. Jpn. J. Cancer Res. 1997, 88(4):356-362.
174. Tanaka T., Iwata H., Niwa K., Mori Y., Mori H. Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male ACI/N rats. Jpn. J. Cancer Res. 1998, 79:1297-1303.
175. Tang Q., Denda A., Tsujiuchi T., Tsutsumi M., Amanuma T., Murata Y., Maruyama H., Konishi Y. Inhibitory effects of inhibitors of arachidonic acid metabolism on the evolution of rat liver preneoplastic foci into nodules and hepatocellular carcinomas with or without phenobarbital exposure. Jpn. J. Cancer Res. 1993, 84:120-127.
176. Tanigawa S., Fujii M., Hou D.X. Stabilization of p53 is involved in quercetin-induced cell cycle arrest and apoptosis in HepG2 cells. Biosci. Biotechnol. Biochem. 2008, 72:797-804.
177. Tharappel J.C., Lehmler H.J., Srinivasan C., Robertson L.W., Spear B.T., Glauert H.P. Effect of antioxidant phytochemicals on the hepatic tumor promoting activity of 3,3',4,4'-tetrachlorobiphenyl (PCB-77). Food Chem. Toxicol. 2008, 46:3467-3474.
178. Trappoliere M., Federico A., Tuccillo C., de Sio I., Di Leva A., Niosi M., D'Auria M., Loguercio C. Effects of a new pharmacological complex (silybin+vitamin-E+phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis Preliminary study. Minerva Gastroenterol. Dietol. 2005, 1:193-199. Real Sud Group 2.
179. Trappoliere M., Federico A., Tuccillo C., de Sio I., Di Leva A., Niosi M., D'Auria M., Loguercio C. Effects of a new pharmacological complex (silybin+vitamin-E+phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis. Preliminary study. Minerva Gastroenterol. Dietol. 2005, 51:193-199. Real Sud Group 2.
180. Tsang W.P., Kwok T.T. Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J. Nutr. Biochem. 2010, 21:140-146.
181. Tsuda H., Uehara N., Iwahori Y., Asamoto M., Iigo M., Nagao M., Matsumoto K., Ito M., Hirono I. Chemopreventive effects of beta-carotene, alpha-tocopherol and five naturallyoccurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo[4,5-f]quinoline in the rat. Jpn. J. Cancer Res. 1994, 85:1214-1219.
182. Umemura T., Kai S., Hasegawa R., Kanki K., Kitamura Y., Nishikawa A., Hirose M. Prevention of dual promoting effects of pentachlorophenol, an environmental pollutant, on diethylnitrosamine-induced hepato- and cholangiocarcinogenesis in mice by green tea infusion. Carcinogenesis 2003, 24(6):1105-1109.
183. Varghese L., Agarwal C., Tyagi A., Singh R.P., Agarwal R. Silibinin efficacy against human hepatocellular carcinoma. Clin. Cancer Res. 2005, 11:8441-8448.
184. Vásquez-Garzón V.R., Arellanes-Robledo J., García-Román R., Aparicio-Rautista D.I., Villa-Treviño S. Inhibition of reactive oxygen species and pre-neoplastic lesions by quercetin through an antioxidant defense mechanism. Free Radic. Res. 2009, 43:128-137.
185. Wang W.Z., Cheng J., Luo J., Zhuang S.M. Abrogation of G2/M arrest sensitizes curcumin-resistant hepatoma cells to apoptosis. FEBS Lett. 2008, 582:2689-2695.
186. Wolter F., Ulrich S., Stein J. Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in colorectal cancer: key role of polyamines?. J. Nutr. 2004, 134:3219-3222.
187. Wu B.W., Li D.F., Ke Z.F., Ma D., Li Y.J., Gang D., Zheng Z.G., Zhang K.J., Zhang Y.H. Expression characteristics of heparanase in colon carcinoma and its close relationship with cyclooxygenase-2 and angiogenesis. Hepatogastroenterology 2010, 57:1510-1514.
188. Yamamoto T., Kajino K., Kudo M., Sasaki Y., Arakawa Y., Hino O. Determination ofthe clonal origin of multiple human hepatocellular carcinomas by cloning and polymerase chain reaction of the integrated hepatitis B virus DNA. Hepatology 1999, 29:1446-1452.
189. Yang H.L., Chen W.Q., Cao X., Worschech A., Du L.F., Fang W.Y., Xu Y.Y., Stroncek D.F., Li X., Wang E., Marincola F.M. Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model. J. Transl. Med. 2009, 7:22.
190. Yee S.B., Lee J.H., Chung H.Y., Im K.S., Bae S.J., Choi J.S., Kim N.D. Inhibitory effects of luteolin isolated from Ixeris sonchifolia Hance on the proliferation of HepG2 human hepatocellular carcinoma cells. Arch. Pharm. Res. 2003, 26:151-156.
191. Yeh T.C., Chiang P.C., Li T.K., Hsu J.L., Lin C.J., Wang S.W., Peng C.Y., Guh J.H. Genistein induces apoptosis in human hepatocellular carcinomas via interaction of endoplasmic reticulum stress and mitochondrial insult. Biochem. Pharmacol. 2007, 73:782-792.
192. Yin M.C., Lin C.C., Wu H.C., Tsao S.M., Hsu C.K. Apoptotic effects of protocatechuic acid in human breast, lung, liver, cervix, and prostate cancer cells: potential mechanisms of action. J. Agric. Food Chem. 2009, 57:6468-6473.
193. Yip E.C., Chan A.S., Pang H., Tam Y.K., Wong Y.H. Protocatechuic acid induces cell death in HepG2 hepatocellular carcinoma cells through a c-Jun N-terminal kinase-dependent mechanism. Cell Biol. Toxicol. 2006, 22:293-302.
194. Yoo D.R., Jang Y.H., Jeon Y.K., Kim J.Y., Jeon W., Choi Y.J., Nam M.J. Proteomic identification of anti-cancer proteins in luteolin-treated human hepatoma Huh-7 cells. Cancer Lett. 2009, 282:48-54.
195. Yoysungnoen P., Wirachwong P., Bhattarakosol P., Niimi H., Patumraj S. Antiangiogenic activity of curcumin in hepatocellular carcinoma cells implanted nude mice. Clin. Hemorheol. Microcirc. 2005, 33:127-135.
196. Yoysungnoen P., Wirachwong P., Bhattarakosol P., Niimi H., Patumraj S. Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice. Clin. Hemorheol. Microcirc. 2006, 34:109-115.
197. Zhang Q., Tang X., Lu Q.Y., Zhang Z.F., Brown J., Le A.D. Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol. Cancer Ther. 2005, 4:1465-1474.
198. Zhang Q., Tang X., Lu Q., Zhang Z., Rao J., Le A.D. Green tea extract and (-)epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Mol. Cancer Ther. 2006, 5:1227-1238.
199. Zhang B., Pan X., Cobb G.P., Anderson T.A. MicroRNAs as oncogenes and tumor suppressors. Dev. Biol. 2007, 302:1-12.